Source - LSE Regulatory
RNS Number : 1276O
Sensyne Health PLC
06 October 2021
 

 

Sensyne Health plc

('Sensyne' of the 'Company')

 

Publication of Annual Report and Accounts and Notice of Annual General Meeting

 

Oxford, UK, and Dover, Delaware, USA, 06 October 2021: Sensyne Health plc (LSE: SENS), the ethical clinical AI company, announces that its Annual Report and Accounts for the 12 months ended 30 April 2021, together with the Notice of Annual General Meeting ('AGM') were posted to shareholders on 5 October 2021.  Copies of both documents are available on the Company's website, www.sensynehealth.com

The AGM will be held at 2:00 pm BST / 9 am ET on Friday, 29 October 2021 at Voco Thames Hotel, Henley Road, Sandford-on-Thames, Oxford OX4 4GX UK and virtually on a video conference.

To join the AGM virtually please contact CSCSensynehealth@consilium-comms.com by close of business on Wednesday 27 October and a link will be provided. The documents are also available in electronic form on the Company's website: https://www.sensynehealth.com/investors.

The Notice of AGM sets out the arrangements for the meeting and how shareholders may vote and ask questions. Any changes to the arrangements for our AGM because of further government guidance or restrictions will be posted on our website.

 

-ENDS-

 

 For more information please contact:

 

Sensyne Health www.sensynehealth.com )

+44 (0) 330 058 1845

Lord (Paul) Drayson PhD FREng, Chief Executive Officer

 

Dr Richard Pye, Chief Financial Officer

 

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+ 44 (0) 20 7418 8900

Dr Christopher Golden

 

James Steel

 

Liberum (Joint Broker)

+ 44 (0) 20 3100 2000

Bidhi Bhoma

 

Euan Brown

 

Consilium Strategic Communications

+44 (0) 7780600290

Mary-Jane Elliott

 

Jessica Hodgson

 

Davide Salvi

 

CSCSensynehealth@consilium-comms.com

 

 

About Sensyne Health

Sensyne Health plc is a clinical AI company that works in partnership with global healthcare organisations to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L).

 

For more information, please visit: www.sensynehealth.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFFIIVLEIIL
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJBell logo

Related Charts